4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Immunotech Biopharm Ltd (6978) operates in the Biotechnology industry and is headquartered in Beijing, China with about 183 employees. Its market capitalization is roughly CNY 228 million. In the fiscal year ended 2025-12-31, 6978 reported CNY 0M in revenue and (CNY 231M) in net income.
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 0M | CNY 0M | CNY 0M | CNY 0M | — |
| Operating Income (EBIT) | (CNY 156M) | (CNY 169M) | (CNY 224M) | (CNY 269M) | — |
| Net Income | (CNY 231M) | (CNY 187M) | (CNY 335M) | (CNY 318M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 603M | CNY 564M | CNY 846M | CNY 879M | — |
| Total Liabilities | CNY 620M | CNY 580M | CNY 675M | CNY 373M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6978 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms